Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional Ablative CO2 Laser-assisted Treatments for Male Pattern Hair Loss
NCT03852992Phase 2Withdrawn
- Sponsor
- University of Minnesota
- Start
- Sep 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minoxidil in male pattern baldness (MPHL), sponsored by University of Minnesota. Planned start Sep 2022; status: withdrawn.
02
Drugs
minoxidil
03
Conditions
male pattern baldness (MPHL)
Beyond the preview
Go deeper on NCT03852992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03852992.